Our QTc Workshop was a Huge Success!

Posted:
1
October 2004

The QTc workshop hosted by Richmond Pharmacology on 29th September was deemed a huge success. Representatives from top pharmaceutical companies gathered at St George's Hospital to enjoy first class seminars given by world leading experts in cardiology.Jörg Täubel, Managing Director of Richmond Pharmacology began the proceedings by welcoming guests and introducing the speakers for the day.Professor John Camm, Chairman of the Department of Cardiac and Vascular Sciences at St George's Hospital Medical School, the first to speak, defined the QT interval and its clinical relevance. He later provided an insight into the factors that influence the QT interval.Dr Elijah Behr from St George's Hospital Medical School gave a detailed presentation on the congenital syndromes of abnormal ventricular repolarisation. Dr Behr also reflected on the important role that pharmacogenomics will play in the development of drugs in the near future.Professor Marek Malik, also from St George's Hospital Medical School took to the rostrum after coffee to talk about the correction or control of the QT interval for heart rate. Later in the day, Professor Malik returned to give an entertaining presentation on how the QT interval should be measured and the possible implications of all these factors in Study Design.After a delicious buffet lunch, Dr Rashmi Shah from the MHRA, gave an insightful presentation on the regulatory aspects of drug induced QTinterval prolongation, and finished the workshop with a talk entitled The Definitive QT Study, which highlighted the importance of inclusion of such studies in adequate drug development programmes.Initial feedback from those that attended the workshop has been outstanding, everyone benefited from the highly educational and enjoyable day.Richmond Pharmacology continues to work closely with St George's Hospital Medical School to ensure we provide the expertise required for QTc studies. For more information on Richmond Pharmacology's QTc capabilities, please visit our services page.The event was filmed and will be available as a DVD pack in November.

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more